Navigation Links
FDA Issues Another Warning on Fake Version of Cancer Drug Avastin
Date:2/6/2013

WEDNESDAY, Feb. 6 (HealthDay News) -- Doctors need to be on the lookout for another counterfeit version of the injectable cancer drug Avastin (bevacizumab), the U.S. Food and Drug Administration warned on Wednesday.

Lab tests revealed that at least one batch of the counterfeit medicine -- distributed by the U.S. company Medical Device King (also known as Pharmalogical) -- contains no active ingredient.

The counterfeit bevacizumab is marketed as Roche's Altuzan, which is not approved for sale in the United States, the FDA noted. The only approved version of bevacizumab for sale in the United States is Avastin, which is marketed by Genentech.

Altuzan 400 mg/16 mL may be counterfeit if it is labeled as batch B6022B01 with an expiration date of November 2013 or batch B6024B01 with an expiration date of February 2013, the agency said.

The FDA also warned doctors, hospitals and patients to "be wary if the price of a medicine sounds too good to be true. Deep discounts may be offered because the product is stolen, counterfeit, substandard or unapproved."

The FDA said it doesn't know at this point if any patients were given the counterfeit version of the drug, the Associated Press reported. Avastin is used to treat colorectal, brain, lung and kidney cancers.

Medical practices that have received any products from Medical Device King, Pharmalogical or Taranis Medical (another company associated with Pharmalogical) should quit using these products because they might prove hazardous or ineffective, the FDA said.

Anyone with these medicines also should contact the FDA's Office of Criminal Investigations to arrange for pickup.

This is the third case of counterfeit Avastin being sold in the United States in the past year, the AP reported.

In February 2012, the agency said it was investigating a batch of counterfeit Avastin distributed to doctors in several states. In April 2012, the FDA warned doctors about fake Avastin distributed by a U.K. company.

Those two cases appeared to involve different networks of distributors than the latest episode, the AP reported.

More information

The MedlinePlus Medical Encyclopedia has more about Avastin (bevacizumab).

-- Robert Preidt

SOURCES: U.S. Food and Drug Administration, news release, Feb. 5, 2013; Associated Press


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. UCSF chancellor issues call-to-arms to patient advocates
2. Radiologists rank themselves as less than competent on health policy issues
3. Genetic abnormalities in benign or malignant tissues predict relapse of prostate cancer
4. FDA Issues Multiple Sclerosis Drug Alert
5. Quality of care, other issues may cause worse results in black prostate cancer surgery patients
6. U.S. Task Force Issues Blood Pressure Guidelines
7. Internists in Washington to discuss patient and professional issues in meetings on Capitol Hill
8. Cheaper drug could lead to serious eye issues
9. Insulite Labs announces the launch of the PCOS Inspiration Hour, a one hour virtual gathering place for women with PCOS and other women’s health issues to come together.
10. LawyersandSettlements.com Issues Report on Prostate Health Claim Lawsuits and Propecia Side Effect Litigation
11. What Men Should Know About Veins: Varicose Veins and Venous Disease are Real Medical Issues
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FDA Issues Another Warning on Fake Version of Cancer Drug Avastin
(Date:6/27/2016)... ... June 27, 2016 , ... TherapySites, ... today its affiliation with Tennessee Counseling Association. This new relationship allows ... the Tennessee Counseling Association, adding exclusive benefits and promotional offers. , "TCA is ...
(Date:6/26/2016)... , ... June 27, 2016 , ... Quality metrics are ... in many ways they remain in the eye of the beholder, according to experts ... publication of The American Journal of Managed Care. For the full issue, click ...
(Date:6/26/2016)... Charlotte, NC (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind ... able to be personalized through a fitness app. The fitness app plans to fix the ... solutions currently only offer a one size fits all type program , They ...
(Date:6/25/2016)... FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial ... Plant City Observer , brings up a new, often overlooked aspect of head lice: the ... closing for fumigation is not a common occurrence, but a necessary one in the event ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin ... injury. Recently, he has implemented orthobiologic procedures as a method for treating his ... of the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... , June 23, 2016  MedSource announced ... as its e-clinical software solution of choice.  This ... best possible value to their clients by offering ... The preferred relationship establishes nowEDC as the EDC ... for MedSource,s full-service clients.  "nowEDC has long been ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
Breaking Medicine Technology: